18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker

Thorax

Volumn 62, Issue 6, 2007, Pages 560-

  Györik, Sándor ^a   Ceriani, L ^a   Menafoglio, A ^a   Gallino, A ^a   Wyttenbach, R ^a  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; STEROID; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; ARTIFICIAL HEART PACEMAKER; DRUG UPTAKE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FOLLOW UP; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LUNG LAVAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PHYSICAL CAPACITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; CARDIOMYOPATHY; CASE REPORT; HEART BLOCK; MALE; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; SYNCOPE;

CARDIOMYOPATHIES; FLUORODEOXYGLUCOSE F18; HEART BLOCK; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS; SYNCOPE;

EID: 34250370772     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.070805     Document Type: Article

References (2)

1. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43.
2. 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-98.